Gene · 3205
Papers4,255
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 4,255
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Modular scaffolding by lncRNA HOXA10-AS promotes oral cancer progression. | Cell Death Dis | 2022 | 35858923 | PubTator, text mining | PubMed |
| Role of Posttranslational Modifications of Proteins in Cardiovascular Disease. | Oxid Med Cell Longev | 2022 | 35855865 | PubTator, text mining | PubMed |
| Biomolecular Condensation: A New Phase in Cancer Research. | Cancer Discov | 2022 | 35852417 | PubTator, text mining | PubMed |
| Hymeglusin Enhances the Pro-Apoptotic Effects of Venetoclax in Acute Myeloid Leukemia. | Front Oncol | 2022 | 35847946 | PubTator, text mining | PubMed |
| Embryonic Programs in Cancer and Metastasis-Insights From the Mammary Gland. | Front Cell Dev Biol | 2022 | 35846378 | PubTator, text mining | PubMed |
| Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The Cancer Genome Atlas Data. | Biomed Res Int | 2022 | 35845958 | PubTator, text mining | PubMed |
| miR-199a-3p/5p regulate tumorgenesis via targeting Rheb in non-small cell lung cancer. | Int J Biol Sci | 2022 | 35844793 | PubTator, text mining | PubMed |
| Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance. | Mol Cancer | 2022 | 35843942 | PubTator, text mining | PubMed |
| Chemosensitivity of gastric cancer: analysis of key pathogenic transcription factors. | J Gastrointest Oncol | 2022 | 35837191 | PubTator, text mining | PubMed |
| An epigenome-wide association study of insulin resistance in African Americans. | Clin Epigenetics | 2022 | 35836279 | PubTator, text mining | PubMed |
| Downregulation of hsa-miR-548d-3p and overexpression of HOXA9 in diffuse large B-cell lymphoma patients and the risk of R-CHOP chemotherapy resistance and disease progression. | Int J Lab Hematol | 2022 | 35830966 | PubTator, text mining | PubMed |
| ASXL1 mutations with serum EPO levels predict poor response to darbepoetin alfa in lower-risk MDS: W-JHS MDS01 trial. | Int J Hematol | 2022 | 35821550 | PubTator, text mining | PubMed |
| LncRNAs as epigenetic regulators of epithelial to mesenchymal transition in pancreatic cancer. | Discov Oncol | 2022 | 35819532 | PubTator, text mining | PubMed |
| Cell fate decisions, transcription factors and signaling during early retinal development. | Prog Retin Eye Res | 2022 | 35817658 | PubTator, text mining | PubMed |
| IDH2: A novel biomarker for environmental exposure in blood circulatory system disorders. | Oncol Lett | 2022 | 35814829 | PubTator, text mining | PubMed |
| Epigenetic and Transcriptomic Programming of HSC Quiescence Signaling in Large for Gestational Age Neonates. | Int J Mol Sci | 2022 | 35806330 | PubTator, text mining | PubMed |
| MicroRNA Methylome Signature and Their Functional Roles in Colorectal Cancer Diagnosis, Prognosis, and Chemoresistance. | Int J Mol Sci | 2022 | 35806286 | PubTator, text mining | PubMed |
| Critical Roles of Circular RNA in Tumor Metastasis via Acting as a Sponge of miRNA/isomiR. | Int J Mol Sci | 2022 | 35806027 | PubTator, text mining | PubMed |
| Liquid-liquid phase separation in tumor biology. | Signal Transduct Target Ther | 2022 | 35803926 | PubTator, text mining | PubMed |
| The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemia. | iScience | 2022 | 35800767 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3205/papers?page=40